Teva Pharmaceutical Industries Limited · TASE:TEVA
Teva Pharmaceutical Industries — J.P. Morgan Healthcare Conference 2020
14 slides from Teva Pharmaceutical Industries's conference presentation, Jan 13, 2020
Slide 1: Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference
Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference Kåre Schultz President & CEO January 13, 2020
Slide 2: Cautionary Note Regarding Forward-Looking Statements
Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainti
Slide 3: Slide 3
Slide 4: Strategy Update
Strategy Update Restructuring Debt and financing Future growth drivers
Slide 5: Restructuring $3bn
Restructuring 13 10 $3bn manufacturing sites manufacturing sites spend base closed or divested being closed or divested reduction achieved 40 offices and Full operational laboratories closed capacity maintained
Slide 6: Restructuring
Restructuring x x xx x xxxx xx xx xx xx x xxxx xx xxxx xxx x x xxxx x x xxx x xx x x x x xx x
Slide 7: Net Debt Development
Net Debt Development $ billions $34 $32 $30 $28 $26 $24 $22 $20 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19
Slide 8: Debt and financing
Debt and financing Liquidity and cash flow will cover bond repayments next 3 years Net debt to EBITDA ratio has started to decline
Slide 9: Future growth: US generics have stabilized
Future growth US generics have stabilized
Slide 10: Future growth: Europe generics and OTC are growing
Future growth Europe generics and OTC are growing
Slide 11: Future growth: China organic growth has started
Future growth China organic growth has started
Slide 12: Future growth: New products
Future growth New products = 8 AJOV Y= = | =Austedo fea = (deutetrabenazine) nl 61mg, 9g, and 12mg tablets rw teva
Slide 13: Strategy Update
Strategy Update Restructuring Debt and financing Future growth drivers
Slide 14: Slide 14
Teva Pharmaceutical Industries — J.P. Morgan Healthcare Conference 2020 on 6ix